Low-dose tumour necrosis factor α and melphalan in hyperthermic isolated limb perfusion

1993 ◽  
Vol 80 (8) ◽  
pp. 995-997 ◽  
Author(s):  
S. Hill ◽  
W. J. Fawcett ◽  
J. Sheldon ◽  
N. Soni ◽  
T. Williams ◽  
...  
Keyword(s):  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Low Dose ◽  
Isolated Limb Perfusion ◽  
Tumour Necrosis Factor Α ◽  
Limb Perfusion ◽  
Factor Α ◽  
Necrosis Factor

Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis

2014 ◽  
Vol 101 (13) ◽  
pp. 1674-1680 ◽  
Author(s):  
D. L. M. van Broekhoven ◽  
J. P. Deroose ◽  
S. Bonvalot ◽  
A. Gronchi ◽  
D. J. Grünhagen ◽  
...  
Keyword(s):  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Aggressive Fibromatosis ◽  
Isolated Limb Perfusion ◽  
Tumour Necrosis Factor Α ◽  
Limb Perfusion ◽  
Factor Α ◽  
Necrosis Factor

Long-term outcome of isolated limb perfusion with tumour necrosis factor-α for patients with melanoma in-transit metastases

2011 ◽  
Vol 98 (11) ◽  
pp. 1573-1580 ◽  
Author(s):  
J. P. Deroose ◽  
D. J. Grünhagen ◽  
A. N. van Geel ◽  
J. H. W. de Wilt ◽  
A. M. M. Eggermont ◽  
...  
Keyword(s):  
Tumour Necrosis Factor ◽  
Tumour Necrosis ◽  
Tumour Necrosis Factor Α ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Limb Perfusion ◽  
Factor Α ◽  
In Transit ◽  
Necrosis Factor
Sign in / Sign up

Export Citation Format

Share Document